不同剂量蔗糖铁诱导家兔绝经后铁蓄积模型的建立及机制初步探讨(4)
[12] Li J，Hou Y，Zhang S，et al.Excess iron undermined bone load-bearing capacity through tumor necrosis factor-alpha-dependent osteoclastic activation in mice[J].Biomed Rep，2013，1(1)：85-88.
[13] Liu G，Men P，Kenner G H，et al.Age-associated iron accumulation in bone：implications for postmenopausal osteoporosis and a new target for prevention and treatment by chelation[J].Biometals，2006，19(3)：245-251.
[14]刘禄林，高超，王啸，等.铁过载对去势大鼠骨代谢的影响[J].中华骨质疏松和骨矿盐疾病杂志，2013，6(4)：314-319.
[15]王啸，刘禄林，赵国阳，等.铁蓄积小鼠去势前后骨吸收活性的差异[J].中国骨质疏松杂志，2015，21(1)：53-58.
[16] Vu'o'ng Lê B，Khorsi-Cauet H，Villegier A S，et al.New rat models of iron sucrose-induced iron overload[J].Exp Biol Med(Maywood)，2011，236(7)：790-799.
[17] Reagan-Shaw S，Nihal M，Ahmad N.Dose translation from animal to human studies revisited[J].Faseb J，2008，22(3)：659-661.
[18] Huang X，Xu Y，Partridge N C.Dancing with sex hormones，could iron contribute to the gender difference in osteoporosis？[J].Bone，2013，55(2)：458-460.
[19] Jeli? M，Cvetkovi? T，Djordjevi? V，et al.Hepcidin and iron metabolism disorders in patients with chronic kidney disease[J].Vojnosanit Pregl，2013，70(4)：368-373.
[20] Ganz T，Nemeth E.Hepcidin and disorders of iron metabolism[J].Annu Rev Med，2011，62：347-360.
[21] Yang Q，Jian J，Katz S，et al.17 beta-Estradiol inhibits iron hormone hepcidin through an estrogen responsive element half-site[J].Endocrinology，2012，153(7)：3170-3178.
[22] Raso G M，Irace C，Esposito E，et al.Ovariectomy and estrogen treatment modulate iron metabolism in rat adipose tissue[J].Biochem Pharmacol，2009，78(8)：1001-1007.
(收稿日期：2018-05-21) (本文編辑：董悦), 百拇医药(邝立鹏 叶燕彬 江山岳 谢成龙 罗玉)
[13] Liu G，Men P，Kenner G H，et al.Age-associated iron accumulation in bone：implications for postmenopausal osteoporosis and a new target for prevention and treatment by chelation[J].Biometals，2006，19(3)：245-251.
[14]刘禄林，高超，王啸，等.铁过载对去势大鼠骨代谢的影响[J].中华骨质疏松和骨矿盐疾病杂志，2013，6(4)：314-319.
[15]王啸，刘禄林，赵国阳，等.铁蓄积小鼠去势前后骨吸收活性的差异[J].中国骨质疏松杂志，2015，21(1)：53-58.
[16] Vu'o'ng Lê B，Khorsi-Cauet H，Villegier A S，et al.New rat models of iron sucrose-induced iron overload[J].Exp Biol Med(Maywood)，2011，236(7)：790-799.
[17] Reagan-Shaw S，Nihal M，Ahmad N.Dose translation from animal to human studies revisited[J].Faseb J，2008，22(3)：659-661.
[18] Huang X，Xu Y，Partridge N C.Dancing with sex hormones，could iron contribute to the gender difference in osteoporosis？[J].Bone，2013，55(2)：458-460.
[19] Jeli? M，Cvetkovi? T，Djordjevi? V，et al.Hepcidin and iron metabolism disorders in patients with chronic kidney disease[J].Vojnosanit Pregl，2013，70(4)：368-373.
[20] Ganz T，Nemeth E.Hepcidin and disorders of iron metabolism[J].Annu Rev Med，2011，62：347-360.
[21] Yang Q，Jian J，Katz S，et al.17 beta-Estradiol inhibits iron hormone hepcidin through an estrogen responsive element half-site[J].Endocrinology，2012，153(7)：3170-3178.
[22] Raso G M，Irace C，Esposito E，et al.Ovariectomy and estrogen treatment modulate iron metabolism in rat adipose tissue[J].Biochem Pharmacol，2009，78(8)：1001-1007.
(收稿日期：2018-05-21) (本文編辑：董悦), 百拇医药(邝立鹏 叶燕彬 江山岳 谢成龙 罗玉)